Has Daniel Xie, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,448 in general payments to Daniel Xie, MD across 100 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Daniel Xie, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Daniel Xie, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Daniel Xie, MD

Dermatology · Henderson, NVNPI 1598384828

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.5% of the total across 100 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 16.4% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for dermatology clinicians in NV, where the typical reported total is $3,854.

$2,448in general payments, 2019–2025

Across 100 payments — averaging $24.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$402
AbbVie$323
Amgen$273
Merz North America, Inc.$179
Pfizer$163
Sanofi$160
plus $946 from 18 others

What the payments were for

Food & beverage$2,23991%
Education$2099%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	13	$402
AbbVie	20	$323
Amgen	14	$273
Merz North America, Inc.	1	$179
Pfizer	10	$163
Sanofi	4	$160
LEO Pharma Inc.	6	$139
Kyowa Kirin, Inc.	1	$120
Sun Pharmaceutical Industries Inc.	4	$92
Arcutis Biotherapeutics, Inc.	4	$73
UCB, Inc.	2	$62
CSL Behring	2	$59
Botanix SB Inc	2	$54
Regeneron Healthcare Solutions, Inc.	2	$50
Lilly USA, LLC	2	$47
Organon	3	$40
Springworks Therapeutics, Inc.	2	$39
Dermavant Sciences, Inc.	2	$31
Boehringer Ingelheim	1	$31
Galderma Laboratories, L.p.	1	$30
Blueprint Medicines Corporation	1	$28
Janssen Scientific Affairs, LLC	1	$22
Incyte Corporation	1	$16
Ortho Dermatologics, A Division Of Bausch Health US, LLC	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

POTELIGEO$120

How this compares

$2,448 in reported general payments places this provider in the 40th percentile of 78 dermatology providers in Nevada.

See all dermatology providers in Nevada →

Medicare billing

Part B allowed, 2024

$32,403

Medicare patients

158

Services billed

639

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Clobetasol Propionate	60	$1,468
Ketoconazole	59	$822
Triamcinolone Acetonide	88	$759
Clindamycin Phosphate	22	$665
Doxycycline Monohydrate	25	$594
Hydrocortisone	25	$131

Paid to pharmacies, not to this prescriber.

Other dermatology in Henderson

Curt SamlaskaHenderson$101K
Robert LiebermanHenderson$22K
Juian-Juian FuHenderson$12K
Cristian GonzalezHenderson$3K
David CotterLas Vegas$1.4M
Harry GreenbergLas Vegas$1.1M
Miriam BettencourtLas Vegas$772K
Victoria FarleyLas Vegas$151K
Laura OstezanReno$27K
Linda WoodsonLas Vegas$22K

See the full list for Nevada →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →